A series of 60 cases of prostatic adenocarcinoma and 34 cases of benign prostatic hyperplasia were examined quantitatively after immunoperoxidase staining for prostate-specific antigen (PSA), prostate-specific acid phosphatase (PSAP), carcino-embryonic antigen (CEA), epithelial membrane antigen (EMA), alpha fetoprotein (AFP), and human chorionic gonadotrophs (HCC). The tumors were graded I to IV according to the MDAH grading system recently proposed. Fifty-nine of the 60 tumors were positive for PSA and 58 were positive for PSAP. The one PSA and PSAP negative case was CEA negative and weakly EMA positive. Grade I to III tumors stained more tumor cells and more diffusely for PSA and PSAP than grade IV tumors. There was no significant difference in the intensity or extent of staining between grade I and grade II-III tumors for PSA and PSAP. A comparison of PSA and PSAP showed that PSA stained more intensely and more extensively than PSAP. Benign prostatic tissue and low-grade prostatic tumors did not stain for CEA but three of the 20 grade IV tumors and one of the 23 grade II-III tumors did. Staining for EMA was focal and showed no relation to tumor grade. Benign and malignant lesions failed to stain for AFP and HCG.
did not stain for PSA. 15 Other tumor markers that had been applied to prostatic cancers and shown to be present in some cases included carcinoembryonic antigen (CEA) 613 and epithelial membrane antigen (EMA).
14 While a comparison of multiple tumor markers in serum of patients with prostatic cancer had been documented, 8 no data are available of a comparative study of multiple tumor markers using the immunoperoxidase technic on benign and malignant prostatic tissue. To more accurately assess and compare the sensitivity of PSA and PSAP and to obtain a profile of other commonly used tumor markers in prostatic carcinoma, this study presents the findings of 100 prostatic biopsies that were stained by the immunoperoxidase technic for PSA, PSAP, CEA, and EMA as well as for human chorionic gonadotrophin (HCG) and alphafetoproteins (AFP).
Materials and Methods
Between November 1981 and August 1982, 100 prostatic biopsies were examined at the Royal Prince Alfred Hospital, Sydney. During this period there were 66 biopsies from 60 patients with carcinoma of the prostate. The remaining 34 biopsies showed benign prostatic hyperplasia randomly selected from the same accession period. The cases so selected were all considered clinically to be prostatic carcinoma or hyperplasia, respectively.
All hematoxylin and eosin stained sections of the cases under study were evaluated, and the malignant tumors were graded from I to IV according to the MDAH system recently reported by Braun et al. 2 We also used a modified grading system and combined grades II and III for the purposes of tabulation.
Formalin-fixed paraffin sections were immunostained by the unlabelled antibody peroxidase-antiperoxidase (PAP) method of Sternberger. 16 PAP kits for the detection of PSA (Dako) and PSAP (Immulok Histoset) were used in accordance with the manufacturer's instructions. Rabbit antihuman CEA, AFP, and B-HCG: swine antirabbit immunoglobulins and PAP soluble complexes were ob- Cross-reactivity of anti-CEA serum with nonspecific cross-reacting glycoproteins was removed by absorption of antiserum with acetone dried powdered human spleen. 10 Control sections were stained in parallel and included omission of the primary antibody and substitution of the primary antibody with nonimmune normal rabbit serum in duplicate sections.
For each section three parameters were quantified: maximum intensity of staining, coded as 0 indicating no staining to 4+ representing highest intensity of staining, extent of staining (the percentage of glandular cells staining positively), and the range of intensity (percentage of positive cells that show the maximum level of staining).
Results
Of the 60 cases of prostatic carcinoma, 17 were grade I, 23 were grade II-III and 20 were grade IV cancers. Those cases that had multiple biopsies showed the same grade for each biopsy.
Prostate Specific Antigen and Prostate Specific Acid Phosphatase
All of the 34 cases of benign hyperplasia showed intense staining (4+) for both PSA and PSAP in more than 75% of the glandular cells ( Figs. 1 and 2 ). Cuboidal and flat glandular cells were less intensely and less consistently stained. Suburethral glands, ductal epithelium, squamous metaplastic cells, and transitional epithelium did not stain for PSA and PSAP. These findings were the same as in previous reports for both PSA 5 and PSAP. 4 The results of the PSA and PSAP stains including the percentage of tumor cells staining positively in the 60 cases of prostatic carcinoma are shown in Tables 1 and  2 , respectively (Figs. 3 and 4). One or 1.6% of cases was PSA negative and 2 or 3.3% of cases were PSAP negative. The PSA-negative case also did not stain for PSAP, while the other PSAP-negative case was PSA positive. Both cases were grade IV lesions and were also CEA negative and weakly EMA positive.
As shown in tables 3 and 4, grade IV tumors stained less intensely for PSA and PSAP with a wider range of intensity than the lower grade lesions. Similarly, grade I to HI tumors tended to stain more tumor cells and more diffusely for PSA and PSAP than grade IV tumors. There was no significant difference in the intensity or extent of staining between grade I and grade II-III tumors for PSA and PSAP. It can be generalized that PSA, on the average, stained a higher percentage of tumor cells and did so more intensely than PSAP. There were 13 cases in which PSA stained a greater percentage of tumor cells than PSAP. In contrast, there were only six cases in which PSAP stained more profusely than PSA. In comparing intensity of staining, there were 31 cases in which PSA stained more intensely than PSAP, while only seven cases in which PSAP stained more intensely than PSA.
Examination of a given area of tumor for PSA and PSAP staining showed a discordant pattern. In some cases, cribriform areas expressed PSA very weakly and PSAP strongly. In other cases, the reverse was true and there was no consistent pattern. 
Epithelial Membrane Antigen
The epithelial component of all 34 cases of benign prostatic hyperplasia stained positively for EMA (Fig. 5) . EMA staining involving over 75% of the benign epithelial cells was observed in three (8.8%) of the cases, 50-75% of the cells in seven (20.6%) of cases, 25-50% of cells in 20 (58.8%) of the cases, and 5-25% of cells in 4 (11.8%) of the cases. EMA staining was located predominately on the luminal border and appeared to be more intense in flattened cells. In contrast, PSA and PSAP were seen more commonly in columnar or high cuboidal epithelial cells.
Of the 60 cases of prostatic carcinoma, EMA stain was negative in 13 (21.7%) of the cases. As shown in Table  5 , there was no correlation between negative EMA cases and the percentage of EMA staining tumor cells to tumor grade. All the EMA negative cases showed strong positivity for PSA and PSAP. Of the cases that stained for EMA, the antigen was located on the luminal border and/or within the cytoplasm. The antigen tended to be located on luminal borders of well-differentiated epithelial cells and within cytoplasm in undifferentiated carcinoma cells (Fig. 6) .
Of the 54 cases of prostatic carcinoma that also contained benign hyperplastic tissue, the findings on EMA staining were similar to the benign prostatic hyperplasia cases.
Carcinoembryonic Antigen
Staining for CEA was negative in all 34 cases of benign prostatic hyperplasia except in areas of squamous metaplastic epithelium.
Only 4 (6.7%) of the 60 cases of prostatic carcinoma stained for CEA (Fig. 7) . All 17 cases of grade I tumors were CEA negative; 1 (4.3%) of 23 grade II-III tumors stained for CEA in less than 5% of tumor cells; and 3 (15.0%) of the 20 grade-IV lesions stained for CEA-in two cases, less than 25% of the tumor cells stained, and in the third case, 50-75% of the tumor cells stained for CEA. All CEA positive cases were also PSA and PSAP positive. Benign prostatic tissue seen in these cancer cases did not stain for CEA.
Alphafetoproteins and Human Chorionic Gonadotrophin
All 100 biopsies of benign and malignant prostatic lesions failed to stain for AFP and HCG.
Discussion
While some reports" 12 claimed 100% sensitivity for both PSA and PSAP in prostatic cancer, this study confirmed the findings of other reports 1 ' 715 that a small percentage of high-grade prostatic adenocarcinomas failed to stain for PSA or PSAP. It was suggested" that reports with negative PSA or PSAP stains probably were due to difference in technique. In this study, the PAP technique was used as recommended by those achieving 100% sensitivity. One (5.0%) of 20 grade IV tumors was PSA negative and two (10.0%) of 20 grade IV tumors were PSAP negative. All the grade I to III tumors were PSA and PSAP positive. It is possible that reports producing 100% sensitivity for PSA and PSAP had in their series tumors with a larger percentage of better differentiated tumors and a relatively low percentage of grade IV lesions.
The volume of tissue available for evaluation could be a factor in producing a negative stain as shown by one of the cases in this series where only one of three biopsies submitted was PSA positive. All three biopsies showed a grade IV tumor. In contrast to grade I to III tumors, which tended to stain more extensively and intensely among the tumor cells for PSA and PSAP, grade IV lesions stained less intensely and less extensively. Furthermore, a number of these stained positively in less than 5% of the tumor cells, stressing the importance of adequate sampling, especially in grade IV tumors. This finding is of particular practical importance in tracing the primary site of a metastatic undifferentiated carcinoma. If both PSA and PSAP stains are negative in a metastatic undifferentiated carcinoma, although a primary in the pros- tate is unlikely, it does not completely exclude it and other modalities of diagnosis, including morphologic appearances of tumor cells, and clinical findings should also be used in conjunction with the PAP technic. Using the MDAH grading system, one case of grade I tumor in this study stained weakly and focally for both PSA and PSAP; however, the tumor consisted of poorly formed glands with nuclear pleomorphism and extensive infiltration. Using the Gleason grading system, 5 this case would have been classified as a higher grade tumor. Generally, the PSA stained more intensely and more extensively within a given tumor than PSAP.
In view of the reported elevation of serum CEA in prostatic carcinoma, 13 and the finding of CEA in prostatic tissue by the immunoperoxidase technic, 6 it is surprising that so few of our cases stained positively for CEA. It was necessary to preabsorb the commercial antibody, because failure to do so led to widespread staining of benign tissue. 10 The concept of CEA as an onco-developmental antigen fits well with our finding that CEA is not expressed in well-differentiated prostatic adenocarcinoma but is present in a percentage of undifferentiated tumors.
The data in this study confirmed that EMA is normally present in prostatic tissue.
14 EMA also showed variable expression in prostatic carcinoma being positive in 80% of cases but appeared to show no relation to tumor grade. As expected, staining for AFP and HCG were negative in benign and malignant prostatic tissue.
The evaluation of multiple tumor markers using the PAP technic on benign and malignant prostatic tumors in this study will provide a better basis and understanding for application in diagnostic work.
